Sexual health
Oxytocin, kisspeptin and PT-141: one long-approved hormone, one master switch, and one molecule with two names.
Covered here: PT-141 · Kisspeptin-10
Oxytocin is a nine-amino-acid hormone made in the hypothalamus, and it is one of the few peptides in this field that is also a long-approved prescription drug, in an injectable form used in obstetric medicine. The research-channel interest in it concerns social and sexual behaviour, mostly from intranasal studies, and that literature is genuinely mixed: individual findings are real, replication has been inconsistent, and the effect sizes in careful studies are smaller than the summaries of them suggest.
Kisspeptin sits upstream of all of it. It is a neuropeptide encoded by the KISS1 gene that signals through its own receptor to drive release of gonadotropin-releasing hormone, which in turn drives LH and FSH. That makes it something close to a master switch for the reproductive axis, which is why it is studied in human endocrinology research, and it is also why a research vial of it is not a consumer product in any sense.
PT-141 and bremelanotide are the same molecule under two names, a melanocortin receptor agonist structurally related to Melanotan II. It is the one compound in this group with an FDA-approved prescription form, approved in 2019 under a brand name, and that approval covers a specific product with a specific reviewed label rather than the molecule in the abstract. We have not yet published a class review for this group, so the reading below is the groundwork: how to weigh a study, and what the research-use category actually means.
Common questions
What is oxytocin, and what does the research report?
Oxytocin is a nonapeptide produced in the hypothalamus, and an injectable form has been an approved prescription drug for decades in obstetric use. The behavioural research, largely intranasal, is where the popular claims come from, and it is a mixed record: real individual findings, inconsistent replication, and smaller effect sizes in the more rigorous studies. It is not a settled literature.
What is kisspeptin, and what does it do?
Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts on its own receptor to stimulate release of gonadotropin-releasing hormone, which drives LH and FSH downstream. Its established role is as an upstream regulator of the reproductive axis, which is well characterised in physiology. It has been used in human endocrinology research and is not an approved drug.
What is PT-141?
PT-141 is a melanocortin receptor agonist structurally related to Melanotan II, and it is the research-channel name for the molecule known in pharmacology as bremelanotide. Unlike most compounds covered on this site, it has an approved prescription form. Research-grade material sold under the PT-141 name is not that approved product.
Is bremelanotide the same as PT-141?
Yes. Bremelanotide is the international nonproprietary name and PT-141 is the development and research-market name for the same molecule. The FDA approved bremelanotide as a prescription drug in 2019 under a brand name. That approval applies to a specific formulation with a reviewed label, and it does not extend to vials sold as research material under the other name.
Is PT-141 safe?
The approved bremelanotide product has an FDA-reviewed safety file, with known cautions documented on its label, because it went through the approval process. Research-grade material sold as PT-141 is a different product with no reviewed file, no label and no verified formulation. Inheriting a safety conclusion from the approved drug to an unverified vial of the same nominal molecule is exactly the error this publication exists to flag.
Read the evidence
4 pieces on this subject, every finding attributed and every gap stated.
Related topics
For research use only · Not for human or veterinary use · No compound discussed here is FDA-approved for any indication